Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2026
Endovascular Management of Moyamoya Type II Endoleak Utilizing a CO2-Assisted Protection Strategy: A Case Report.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fukunishi Takuma, Nawata Shintaro, Nishimaki Hiroshi, Yamazaki Yoshiki, Kinebuchi Satoshi, Tomimoto Daijyun, Komagamine Masahide, Nawata Kan
Аннотация
PURPOSE: To describe the successful treatment of a Moyamoya type II endoleak (T2EL) using n-butyl cyanoacrylate (NBCA) assisted by intra-arterial carbon dioxide (CO2) flow modulation in a patient with post-endovascular abdominal aortic repair (EVAR) aneurysm sac enlargement.
CASE REPORT: An 84-year-old woman developed progressive aneurysm enlargement due to a refractory Moyamoya T2EL 5 years after EVAR with an AFX II stent graft. Angiography demonstrated persistent retrograde perfusion through the inferior mesenteric artery via complex vasa vasorum-dominant collaterals. Because of unfavorable flow dynamics for embolization, CO2 was intentionally injected to transiently suppress antegrade flow from the sigmoid artery, generating a controlled "to-and-fro" pattern. Under these hemodynamic conditions, NBCA was carefully administered, resulting in complete occlusion of the endoleak without reflux or non-target embolization. Follow-up computed tomography (CT) at 1 year confirmed stable sac size with no re-dilation.Clinical ImpactMoyamoya type II ELs are associated with microcollateral networks that complicate embolization and increase the risk of sac enlargement. Although NBCA can penetrate complex channels, reflux poses a significant hazard. In this case, targeted CO2 injection effectively displaced competing flow, enabling safe, selective NBCA deposition. This CO2-assisted strategy represents a feasible option for treating anatomically complex, refractory type II endoleaks.
CASE REPORT: An 84-year-old woman developed progressive aneurysm enlargement due to a refractory Moyamoya T2EL 5 years after EVAR with an AFX II stent graft. Angiography demonstrated persistent retrograde perfusion through the inferior mesenteric artery via complex vasa vasorum-dominant collaterals. Because of unfavorable flow dynamics for embolization, CO2 was intentionally injected to transiently suppress antegrade flow from the sigmoid artery, generating a controlled "to-and-fro" pattern. Under these hemodynamic conditions, NBCA was carefully administered, resulting in complete occlusion of the endoleak without reflux or non-target embolization. Follow-up computed tomography (CT) at 1 year confirmed stable sac size with no re-dilation.Clinical ImpactMoyamoya type II ELs are associated with microcollateral networks that complicate embolization and increase the risk of sac enlargement. Although NBCA can penetrate complex channels, reflux poses a significant hazard. In this case, targeted CO2 injection effectively displaced competing flow, enabling safe, selective NBCA deposition. This CO2-assisted strategy represents a feasible option for treating anatomically complex, refractory type II endoleaks.